Thu, 07 Feb 2013 | BUSINESS SALE
GlaxoSmithKline (GSK) is investigating a sale of its drinks businesses, Lucozade and Ribena.
After announcing its plans for a strategic review of its business, the pharmaceutical group received immediate interest from investment banks regarding the potential sale of some of its more successful brands. Once the deal has been finalised, estimates suggest that the brands could sell for around £766 million.
GSK announced the review of its businesses alongside figures for the fourth quarter, which showed a 35 per cent decline on the previous year's final quarter.
Bankers were quick to signal their interest in the potential sale as Sir Andrew Witty, chief executive at GSK, quipped when asked how long it had taken for bankers to get in touch: “I'm surprised it took as long as 18 minutes.”
Reports from Reuters state that he added: “No decisions have been taken or options ruled out – we could increase investments in certain parts of the world, find a partner or divest the products.”
However, the strong success of the brands is pushing the company towards the business sale option.
Both Lucozade and Ribena are firmly rooted in the European market, with Ribena clocking up most of its sales in the home UK market. This is in contrast to some of GSK's other nutritional products, such as Horlicks, which has made a big impact on some of the emerging markets such as India.
The company is an automatic and industrial door supplier, installing a variety of systems, including but not limited to, automatic doors, fire resistant shutters, entrance barriers, roller shutters and garage doors.
Well-established company operating for over 23 years. Offers a range of driving positions, which include day runs, local runs, local shunting, nights out and tramping.
The company is a business-to-business wholesaler of cask ales, continental lagers, and craft cider. Since its establishment, the business has cultivated strong relationships with high-profile and local breweries, gaining exclusive access to their pro...
Please choose your settings for this site below. For more information please read our Cookie Policy
These cookies are necessary for our website to function properly and provide you with access to all features.
These are analytics cookies that help us to improve the way our website works.
These are used to improve the functional performance of the website and make it easier for you to use.